Terms: = Liver cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP AND Treatment
12 results:
1. The expression and clinical value of LRP11, fubp1 and TET1 in cervical cancer.
Zhao X; Li S; Wen J; Li Y
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):80-84. PubMed ID: 37715422
[TBL] [Abstract] [Full Text] [Related]
2. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
[TBL] [Abstract] [Full Text] [Related]
3. The Reverse Warburg Effect is Associated with fbp2-Dependent Hif1α Regulation in cancer Cells Stimulated by Fibroblasts.
Duda P; Janczara J; McCubrey JA; Gizak A; Rakus D
Cells; 2020 Jan; 9(1):. PubMed ID: 31947613
[TBL] [Abstract] [Full Text] [Related]
4. Association of Leukemia Target Genes
Li J; Zhang W; Liu W; Rong J; Chen Y; Gu W; Zhang W
Cancer Genomics Proteomics; 2019; 16(5):333-344. PubMed ID: 31467227
[TBL] [Abstract] [Full Text] [Related]
5. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis.
Poole MI; Sorribes I; Jain HV
Math Biosci; 2018 Dec; 306():186-196. PubMed ID: 30312632
[TBL] [Abstract] [Full Text] [Related]
6. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells.
Krause GC; Lima KG; Haute GV; Schuster AD; Dias HB; Mesquita FC; Pedrazza L; Marczak ES; Basso BS; Velasque AC; Martha BA; Nunes FB; Donadio MV; de Oliveira JR
Biomed Pharmacother; 2017 May; 89():358-365. PubMed ID: 28242545
[TBL] [Abstract] [Full Text] [Related]
7. Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2 cell proliferation via increase of free radicals and apoptosis.
da Silva EF; Krause GC; Lima KG; Haute GV; Pedrazza L; Mesquita FC; Basso BS; Velasquez AC; Nunes FB; de Oliveira JR
Oncol Rep; 2016 Nov; 36(5):2647-2652. PubMed ID: 27665945
[TBL] [Abstract] [Full Text] [Related]
8. Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy.
Song JH; Son SH; Kay CS; Jang HS
Oncotarget; 2015 Oct; 6(32):33952-60. PubMed ID: 26376679
[TBL] [Abstract] [Full Text] [Related]
9. Alternative splicing of fbp-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
[TBL] [Abstract] [Full Text] [Related]
10. Anti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cells.
Zhang Y; Owusu L; Duan W; Jiang T; Zang S; Ahmed A; Xin Y
Int J Mol Med; 2013 Oct; 32(4):959-64. PubMed ID: 23863984
[TBL] [Abstract] [Full Text] [Related]
11. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery.
Lu PL; Chen YC; Ou TW; Chen HH; Tsai HC; Wen CJ; Lo CL; Wey SP; Lin KJ; Yen TC; Hsiue GH
Biomaterials; 2011 Mar; 32(8):2213-21. PubMed ID: 21176954
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.
Malz M; Weber A; Singer S; Riehmer V; Bissinger M; Riener MO; Longerich T; Soll C; Vogel A; Angel P; Schirmacher P; Breuhahn K
Hepatology; 2009 Oct; 50(4):1130-9. PubMed ID: 19585652
[TBL] [Abstract] [Full Text] [Related]
